Cargando…
Cancer drug resistance in multiple myeloma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255243/ https://www.ncbi.nlm.nih.gov/pubmed/35800374 http://dx.doi.org/10.20517/cdr.2022.32 |
| _version_ | 1784740884921712640 |
|---|---|
| author | Uckun, Fatih M. |
| author_facet | Uckun, Fatih M. |
| author_sort | Uckun, Fatih M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9255243 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | OAE Publishing Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92552432022-07-06 Cancer drug resistance in multiple myeloma Uckun, Fatih M. Cancer Drug Resist Editorial OAE Publishing Inc. 2022-03-25 /pmc/articles/PMC9255243/ /pubmed/35800374 http://dx.doi.org/10.20517/cdr.2022.32 Text en © The Author(s) 2022. https://creativecommons.org/licenses/by/4.0/© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Editorial Uckun, Fatih M. Cancer drug resistance in multiple myeloma |
| title | Cancer drug resistance in multiple myeloma |
| title_full | Cancer drug resistance in multiple myeloma |
| title_fullStr | Cancer drug resistance in multiple myeloma |
| title_full_unstemmed | Cancer drug resistance in multiple myeloma |
| title_short | Cancer drug resistance in multiple myeloma |
| title_sort | cancer drug resistance in multiple myeloma |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255243/ https://www.ncbi.nlm.nih.gov/pubmed/35800374 http://dx.doi.org/10.20517/cdr.2022.32 |
| work_keys_str_mv | AT uckunfatihm cancerdrugresistanceinmultiplemyeloma |